You have 0 free disease views remaining today. Register for more view, it is 100% free →
acute hemorrhagic encephalitis
Description
Acute Hemorrhagic Leukoencephalitis (AHLE): A Rare and Severe Central Nervous System Disorder
Acute hemorrhagic leukoencephalitis (AHLE), also known as Hurst disease, is a rare and severe form of acute disseminated encephalomyelitis (ADEM). It is characterized by a brief yet intense inflammation in the brain and spinal cord that damages the myelin, the protective covering of the nerve fibers [3][5]. This inflammation can lead to bleeding in the brain, causing damage to the white matter [3].
Key Features
- Rapid progression: AHLE is marked by rapid progression and acute inflammation of the central nervous system (CNS) [6].
- Hemorrhagic lesions: The disease is characterized by hemorrhagic CNS demyelinating lesions with oedema and mass effect [7].
- High morbidity and mortality: AHLE has a very high morbidity and mortality rate, making it a severe and potentially life-threatening condition [7].
Causes and Triggers
While the exact cause of AHLE is unknown, it is believed to be triggered by an autoimmune response to myelin antigens in some cases [12]. In other instances, it may follow acute respiratory illnesses or viral infections [1][8].
Symptoms and Diagnosis
The symptoms of AHLE can vary but often include acute encephalopathy, multifocal deficits, and hemorrhagic CNS demyelinating lesions [7]. Early diagnosis is crucial for proper management and improving prognosis [8].
Treatment and Prognosis
There is no specific treatment for AHLE, and the disease has a generally poor prognosis. However, significant variation in outcomes has been observed, with some patients experiencing complete recovery [5][11].
References:
[1] Context result 1 [3] Context result 3 [5] Context result 5 [6] Context result 6 [7] Context result 7 [8] Context result 8
Additional Characteristics
- A rare and severe form of acute disseminated encephalomyelitis (ADEM)
- Characterized by a brief yet intense inflammation in the brain and spinal cord that damages the myelin, the protective covering of the nerve fibers
- Hemorrhagic CNS demyelinating lesions with oedema and mass effect
- Triggers include autoimmune response to myelin antigens, acute respiratory illnesses, or viral infections
- Symptoms include acute encephalopathy, multifocal deficits, and hemorrhagic CNS demyelinating lesions
Signs and Symptoms
Symptoms of Acute Hemorrhagic Leukoencephalitis (AHLE)
Acute hemorrhagic leukoencephalitis (AHLE) is a rare and severe form of encephalomyelitis, characterized by a brief but intense attack of inflammation in the brain and spinal cord. The symptoms of AHLE can be severe and include:
- Fever: A high temperature, often accompanied by other symptoms such as headache and altered mental status [1].
- Headache: A severe headache that may be accompanied by other symptoms such as fever and altered mental status [2].
- Altered mental status: Confusion, disorientation, or changes in personality [3].
- Seizures: Seizures can occur due to the inflammation and damage to the brain [4].
- Focal neurologic deficits: Weakness or paralysis of one side of the body, or other specific neurological symptoms such as difficulty speaking or swallowing [5].
- Gastrointestinal (GI) or respiratory prodrome: Some people may experience a mild illness before developing AHLE, which can include symptoms such as nausea and vomiting or upper respiratory infection [6].
In severe cases, AHLE can progress rapidly to coma and death. The prognosis for AHLE is poor, with death usually occurring within a week of onset due to increased intracranial pressure (ICP) control [3].
References:
[1] Context result 2 [2] Context result 5 [3] Context result 3 [4] Context result 9 [5] Context result 7 [6] Context result 6
Diagnostic Tests
Diagnostic Tests for Acute Hemorrhagic Leukoencephalitis (AHLE)
Acute hemorrhagic leukoencephalitis (AHLE) is a rare and severe form of encephalitis, and its diagnosis can be challenging. However, several diagnostic tests can help confirm the condition.
- Magnetic Resonance Imaging (MRI): MRI is considered a crucial tool in diagnosing AHLE. It can show mass-like lesions, hemorrhages, and edema in the brain [5]. MRI findings are often described as showing "large confluent lesions" with hemorrhages [14].
- Computed Tomography (CT) scans: CT scans can also be used to diagnose AHLE, although they may not be as sensitive as MRI. They can show areas of bleeding and edema in the brain [3].
- Cerebrospinal Fluid (CSF) analysis: CSF tests are often positive for increased protein levels and leukocytosis in patients with AHLE [7]. However, these findings alone may not be sufficient to confirm the diagnosis.
- Brain biopsy: In some cases, a brain biopsy may be necessary to confirm the diagnosis of AHLE. This involves taking a sample of brain tissue for examination under a microscope [5].
- Other diagnostic tests: Other diagnostic tests that may
Additional Diagnostic Tests
- Magnetic Resonance Imaging (MRI)
- Computed Tomography (CT) scans
- Other diagnostic tests
- Brain biopsy
- Cerebrospinal Fluid (CSF) analysis
Treatment
Treatment Options for Acute Hemorrhagic Leukoencephalitis (AHLE)
Acute hemorrhagic leukoencephalitis (AHLE) is a rare and severe form of encephalomyelitis, characterized by inflammation and bleeding in the brain. The treatment of AHLE is primarily focused on reducing inflammation, controlling symptoms, and supporting the patient's overall health.
First-Line Treatment
High-dose intravenous corticosteroids are considered the first-line treatment for AHLE [4][14]. This approach aims to reduce inflammation and swelling in the brain, thereby alleviating symptoms. Corticosteroids, such as methylprednisolone, have been shown to be effective in reducing mortality rates and improving outcomes in patients with AHLE.
Alternative Treatment Options
In addition to corticosteroids, other treatment options may include:
- Plasma exchange: This procedure involves removing plasma from the blood and replacing it with a substitute solution. Plasma exchange has been used to treat AHLE, particularly when there is significant bleeding or edema in the brain [5][12].
- Intravenous immunoglobulin (IVIG): IVIG involves administering antibodies that can help reduce inflammation and modulate the immune response. This treatment option may be considered for patients with AHLE who do not respond to corticosteroids or have severe symptoms [5][15].
Supportive Care
Supportive care, such as managing increased intracranial pressure, maintaining a stable blood pressure, and providing nutritional support, is essential in the management of AHLE. In some cases, patients may require mechanical ventilation or other life-support measures to manage respiratory failure.
It's worth noting that treatment outcomes for AHLE can vary significantly depending on the severity of symptoms, underlying health conditions, and promptness of medical intervention. Early recognition and aggressive treatment are critical in improving patient outcomes.
References:
[4] Alromaihi M. High-dose IV steroids remain first-line treatment for acute hemorrhagic leukoencephalitis. [5] Seales D. Successful outcome with aggressive treatment of acute hemorrhagic leukoencephalitis. [12] Ray BKSARS-CoV-2-associated acute hemorrhagic, necrotizing encephalitis (AHNE) presenting with cognitive impairment in a 44-year-old woman without comorbidities: a case report.
Recommended Medications
- Plasma exchange
- Intravenous immunoglobulin (IVIG)
- High-dose intravenous corticosteroids
- 6alpha-methylprednisolone
- Methylprednisolone
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Differential Diagnoses for Acute Hemorrhagic Encephalitis
Acute hemorrhagic encephalitis (AHE) is a rare and severe condition characterized by bleeding in the brain. When diagnosing AHE, it's essential to consider other potential causes of similar symptoms. Here are some differential diagnoses that may be considered:
- Herpes Simplex Encephalitis: This viral infection can cause inflammation and bleeding in the brain, particularly in the temporal lobes [1].
- Acute Disseminated Encephalomyelitis (ADEM): ADEM is a rare autoimmune disorder that can cause inflammation and damage to the brain's white matter [6].
- Multiple Sclerosis: This chronic condition can cause demyelination and inflammation in the central nervous system, which may be mistaken for AHE [12].
- Acute Necrotizing Encephalopathy (ANE): ANE is a rare condition characterized by symmetrical, multifocal lesions in the brain, often associated with edematous necrosis and hemorrhage [2].
- Susac Syndrome: This rare autoimmune disorder can cause inflammation and damage to the brain's white matter, which may be mistaken for AHE [12].
Other Considerations
In addition to these differential diagnoses, other conditions that may need to be ruled out include:
- Arterial or Venous Infarct: A stroke can cause bleeding in the brain, which may be mistaken for AHE.
- Severe Hypoxia or Traumatic Injury: These conditions can cause damage to the brain and lead to symptoms similar to AHE.
- Toxins Resulting in Brain Damage: Exposure to certain toxins can cause inflammation and damage to the brain, leading to symptoms similar to AHE.
References
[1] Context 3: Herpes simplex encephalitis is a viral infection that usually involves the limbic system, sparing the basal ganglia. [2] Context 2: Acute necrotizing encephalopathy (ANE) might be another differential diagnosis in this case. [6] Context 6: Marburg variant. Balo concentric sclerosis. Schilders variant. acute hemorrhagic leukoencephalitis (Hurst disease) CLIPPERS. myelin oligodendrocyte glycoprotein antibody ... [12] Context 12: General imaging differential considerations include: Susac syndrome. acute necrotizing encephalitis of childhood (ANEC) 7. multiple sclerosis. Marburg variant. Balo concentric sclerosis. Schilders variant. acute hemorrhagic leukoencephalitis (Hurst disease) CLIPPERS. myelin oligodendrocyte glycoprotein antibody ...
Additional Differential Diagnoses
- Herpes Simplex Encephalitis
- Acute Necrotizing Encephalopathy (ANE)
- N syndrome
- multiple sclerosis
- acute disseminated encephalomyelitis
Additional Information
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:5224
- core#notation
- DOID:5224
- oboInOwl#hasDbXref
- UMLS_CUI:C1332149
- rdf-schema#label
- acute hemorrhagic encephalitis
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/doid#NCIthesaurus
- rdf-schema#subClassOf
- http://purl.obolibrary.org/obo/DOID_9588
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_11402
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.